Skip to content
Ibumix
  • Technology
    • Bioavailability
    • The tablet problem
    • Lipid & liquid-crystal delivery
    • GRAS & established materials
    • TECHNOLOGY – The Ibumix™ Platform
    • Science and data
    • The Structural Problem Behind Poor Drug Solubility
    • Products
    • Drug-delivery and formulation glossary
  • Company
    • About Ibumix
    • Investor overview
    • Newsroom
    • Connect
  • Insights
Ibumix
  • Technology
    • Bioavailability
    • The tablet problem
    • Lipid & liquid-crystal delivery
    • GRAS & established materials
    • TECHNOLOGY – The Ibumix™ Platform
    • Science and data
    • The Structural Problem Behind Poor Drug Solubility
    • Products
    • Drug-delivery and formulation glossary
  • Company
    • About Ibumix
    • Investor overview
    • Newsroom
    • Connect
  • Insights

Tag: NSAID

6 September 20266 September 2026TechnologyBy George Forrest

The Molecule Must Earn the Patch

Five NSAIDs from one pharmacological class have five different transdermal fates. No molecular descriptor predicts which, and neither does the flux calculation that comes closest.

Read more
5 June 20266 September 2026TechnologyBy George Forrest

Naproxen: A Case Study in Conservative Formulation

When a superior molecule is held back by its delivery system Naproxen’s long-lasting effect is well known. Its slow start is the […]

Read more
13 May 202613 May 2026TechnologyBy George Forrest

Almost 100% Absorbed. Almost Always Late.

Why ibuprofen is the cleanest test case in the world for a new generation of drug delivery — and the molecule on […]

Read more
© 2026 Ibumix.